RIGL stock


Rigel Pharmaceuticals, Inc. (RIGL) Says FDA Not Planning an AdCom for Fostamatinib NDA; Shares Jump 30%

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors have a smile on their faces Monday morning, after the drug maker announced that the FDA is currently …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts